FDA Prediction, page-22

Recently Rap news shut up a lot of negative voice but still some remaining. FDA delay caused by mid year backlog nothing else, it is currently back on track.

It’s in pipeline atm both experien group and management are confident with but they won’t officially tell investors. Grant is a matter of time that Morgan estimate it will be CY2019. The good thing is market has not priced in the approval but has decided to march on without it, this is not something we don’t need to worry about everyday.